YahooAugust 20, 2026 at 11:46 AM NY15 days ago

Should Investors Buy STERIS as Growth Meets Reasonable Valuation?

STE enters fiscal 2027 with solid growth, recurring healthcare demand and better margins, but tariffs and investment needs temper the valuation case.

Read the Full Story at the Source

The summary here comes from the news provider; the rest of the article lives on the publisher's site — Yahoo

Companies in This Story